Subscribe
Sign in
Home
Podcast
The Precision Premium
FemmeHealth Alliance
My Health & Fitness Playbook
About
Latest
Top
Discussions
The Signals I’m Watching in Women’s Health as 2026 Approaches
An investor’s perspective on how distribution power, evidence standards, and structural risk are quietly reshaping women’s health heading into 2026.
Dec 28, 2025
•
Maryann
23
6
4
What 2025 Taught Investors About Healthcare
An investor’s analysis of how the 2025 healthcare market reset reshaped capital allocation and why women’s health was disproportionately exposed.
Dec 20, 2025
•
Maryann
15
4
4
Why Women’s Health and Women’s Wealth Are Not Separate Conversations
How capital systems shape outcomes, access, and long-term security
Dec 13, 2025
•
Maryann
32
6
10
What Women Already Knew About Telehealth
and what the rest of the world is only now beginning to understand.
Dec 7, 2025
•
Maryann
52
5
8
November 2025
The Most Dangerous Myth in Medicine: The Average Patient
What an AI dosing error, a stock-market collapse, and a forgotten heart-drug study reveal about the future of precision health.
Nov 23, 2025
•
Maryann
48
19
16
The 150-Minute Myth: Why Women’s Hearts Were Never Playing by the Rules
A groundbreaking Nature study reveals that women gain far more heart protection from far less exercise and exposes the quiet bias built into decades of…
Nov 16, 2025
•
Maryann
75
17
16
Tough Love for Women’s Health Founders
Lisa Suennen on What VCs Really Think and Why Passion Isn’t a Business Model
Nov 6, 2025
•
Maryann
14
3
26:50
When Care Becomes Capital: Inside the $18 Billion Women’s Health Deal Reshaping Medicine
Blackstone and TPG’s acquisition of Hologic isn’t just a medtech move. It’s a cultural signal. Here’s what it reveals about the next trillion-dollar…
Nov 2, 2025
•
Maryann
31
6
14
October 2025
The Billion Dollar Blind Spot: Why We Built the FemmeHealth Alliance
When ideas mature into infrastructure: reflections on the launch of the FemmeHealth Alliance and the next chapter of The Billion Dollar Blind Spot.
Oct 26, 2025
•
Maryann
21
6
Being Female Is Not a Disease: The Untapped Investment Opportunity in Women’s Health
From hysteria to antidepressants, medicine has long medicalized women’s distress instead of solving it. Here’s why that blind spot is also a…
Oct 19, 2025
•
Maryann
41
5
12
Why Gender Medicine Matters for Investors
Gender medicine isn’t a niche. It’s the next frontier of precision health and economic efficiency. As data becomes more inclusive, both care and capital…
Oct 15, 2025
25
2
5
The Business of Women's Health
How women’s health became medicine’s biggest blind spot and investors’ next opportunity.
Oct 12, 2025
33
6
14
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts